Skip to main content
. 2013 Mar;20(3):350–357. doi: 10.1128/CVI.00630-12

Table 1.

iPCR DNA oligonucleotide sequences used in this study

Oligonucleotide no. Oligonucleotide identification Sequence (5′–3′)a
T1 Template 1 (IgG coupled) Biotin-AGCCTCAGACCAAGCCAGACAACTGCCTCGTGACGTTGCTGCCCCTACCAACGTACCCCTACGAGTCC
T1F Template 1 forward AGCCTCAGACCAAGCCAGAC
T1R Template 1 reverse GGACTCGTAGGGGTACGTTGG
T1P Template 1 probe FAM-ACTGCCTCGTGACGTTGCTGCCCCT-BHQ1
T2 Template 2 (IgM coupled) Biotin-AGGAGGAGGGTCAAGTCACCAACGCTGCTCCAGGCCATCGTGCTGATCTGGACCCTGGATCGAGTGA
T2F Template 2 forward AGGAGGAGGGTCAAGTCACC
T2R Template 2 reverse TCACTCGATCCAGGGTCCAG
T2P Template 2 probe MAX-ACGCTGCTCCAGGCCATCGTGCTGA-BHQ1
P1 OspC partial HA forward cgggatcccatatgTGTAATAATTCAGGGAAAGATGG
P2 OspC HA reverse acgcgtcgacTTAcgcataatccggcacatcatacggataAGGTTTTTTTGGACTTTCTGC
P3 BmpA partial myc forward cgggatcccatATGTGTAGTGGTAAAGGTAGTCTTG
P4 BmpA myc reverse acgcgtcgacTTAcagatcttcttcagaaataagtttttgttcAATAAATTCTTTAAGAAACTTCTCATAAC
P5 C6 Bb forward cgggatcccatATGAAGAAGGATGATCAGATTG
P6 C6 Bb reverse acgcgtcgacTTACTTCACAGCAAACTTTCCATC
a

Lowercase letters indicate nontemplate sequence used for addition of terminal restriction sites and/or epitope tags. BHQ1, black hole quencher 1.

HHS Vulnerability Disclosure